Cancer Chemotherapy and Pharmacology,volume 66,issue 5  (10-2010)

Period of time: 2010年5期

Publisher: Springer Publishing Company

Founded in: 1978

Total resources: 46

ISSN: 0344-5704

Subject: R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cancer Chemotherapy and Pharmacology,volume 66,issue 5

Menu

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer

By Sabharwal A.,Corrie P.,Midgley R.,Palmer C.,Brady J.,Mortimer P.,Watson A.,Margison G.,Middleton M. in (2010)

Cancer Chemotherapy and Pharmacology,volume 66,issue 5 , Vol. 66, Iss. 5, 2010-10 , pp. 829-835

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study

By Prete Salvatore,Montella Liliana,Caraglia Michele,Maiorino Luigi,Cennamo Gregorio,Montesarchio Vincenzo,Piai Guido,Febbraro Antonio,Tarantino Luciano,Capasso Elena,Palmieri Giovannella,Guarrasi Rosario,Bianco Maddalena,Mamone Rosanna,Savastano Clementina,Pisano Agata,Vincenzi Bruno,Sabia Antonietta,D’Agostino Alberto,Faiola Vincenzo,Addeo Raffaele in (2010)

Cancer Chemotherapy and Pharmacology,volume 66,issue 5 , Vol. 66, Iss. 5, 2010-10 , pp. 837-844

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer

By Sehouli Jalid,Camara Oumar,Mahner Sven,Bauknecht Thomas,Lichtenegger Werner,Runnebaum Ingo,Look Katherine,Jaenicke Fritz,Oskay-Oezcelik Guelten in (2010)

Cancer Chemotherapy and Pharmacology,volume 66,issue 5 , Vol. 66, Iss. 5, 2010-10 , pp. 861-868

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

By Ackler Scott,Mitten Michael,Foster Kelly,Oleksijew Anatol,Refici Marion,Tahir Stephen,Xiao Yu,Tse Christin,Frost David,Fesik Stephen,Rosenberg Saul,Elmore Steven,Shoemaker Alexander in (2010)

Cancer Chemotherapy and Pharmacology,volume 66,issue 5 , Vol. 66, Iss. 5, 2010-10 , pp. 869-880

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

By Kwon Jung,Kim Jung,Lee Jung-Ae,Shin Hyun,Kim Hyo,Song Hun,Jung Joo,Kim Ho,Choi Dae,Kim Hyeong,Park Young-iee,Zang Dae in (2010)

Cancer Chemotherapy and Pharmacology,volume 66,issue 5 , Vol. 66, Iss. 5, 2010-10 , pp. 889-897

Springer Publishing Company

Abstract Access to resources Recommend Favorite